bpc-157 adverse events case report human Is BPC‑157 a Risk? Safety, Side Effects, and Concerns Explained A few months ago I
Description
Experiments using FITC-phalloidin staining have revealed that BPC-157 is a potent stimulator of F-actin formation in fibroblasts [11]
It is reasonable to treat the synkinesis once 12 months have elapsed since the acute event, even if mild, to avoid interfering with reinnervation
Those allergic to vitamin B12 or cobalt should avoid them
It is a vicious cycle
